Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to investigate the effects of tafamidis on the intervals of the electrocardiogram, specifically the rate corrected QT interval (QTc) in healthy volunteers.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Basic Science


Related Conditions & MeSH terms


NCT number NCT01775761
Study type Interventional
Source Pfizer
Contact
Status Completed
Phase Phase 1
Start date January 2013
Completion date April 2013

See also
  Status Clinical Trial Phase
Completed NCT01655511 - Safety And Pharmacokinetic Assessment Of Orally Administered Tafamidis In Healthy Volunteers Phase 1